These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 39333335)
1. Exploring and validating the necroptotic gene regulation and related lncRNA mechanisms in colon adenocarcinoma based on multi-dimensional data. Wang W; Liu Y; Wang Z; Tan X; Jian X; Zhang Z Sci Rep; 2024 Sep; 14(1):22251. PubMed ID: 39333335 [TBL] [Abstract][Full Text] [Related]
2. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J Front Immunol; 2022; 13():881359. PubMed ID: 35911752 [TBL] [Abstract][Full Text] [Related]
3. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction. Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859 [TBL] [Abstract][Full Text] [Related]
4. The Diagnostic and Prognostic Value of Neurotransmitter Receptor-Related Genes in Colon Adenocarcinoma. Hu J; Wu Y; Dong X; Zeng Y; Wang Y Mol Biotechnol; 2024 Oct; 66(10):2934-2945. PubMed ID: 37833465 [TBL] [Abstract][Full Text] [Related]
5. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction. Wang Z; Niu D Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070 [TBL] [Abstract][Full Text] [Related]
6. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related]
7. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma. Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A Front Oncol; 2022; 12():941156. PubMed ID: 36505813 [TBL] [Abstract][Full Text] [Related]
8. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. Sun K; Huang C; Li JZ; Luo ZX World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777 [TBL] [Abstract][Full Text] [Related]
9. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms. Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936 [TBL] [Abstract][Full Text] [Related]
10. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma. Huang W; Liu Z; Li Y; Liu L; Mai G J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma. Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882 [TBL] [Abstract][Full Text] [Related]
12. Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs. Hao Z; Liang P; He C; Sha S; Yang Z; Liu Y; Shi J; Zhu Z; Chang Q BMC Bioinformatics; 2022 Oct; 23(1):435. PubMed ID: 36258178 [TBL] [Abstract][Full Text] [Related]
13. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature. Chen W; Lin W; Wu L; Xu A; Liu C; Huang P Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523 [No Abstract] [Full Text] [Related]
14. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis. Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X Front Immunol; 2022; 13():1085038. PubMed ID: 36618366 [TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Prognostic Model for Esophageal Adenocarcinoma Based on Necroptosis-Related Genes. Zhang S; Liu S; Lin Z; Zhang J; Lin Z; Fang H; Hu Z Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553511 [TBL] [Abstract][Full Text] [Related]
16. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma. He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma. Zhang J; Liu Z; Chen W; Liu H Transl Cancer Res; 2023 Sep; 12(9):2239-2255. PubMed ID: 37859737 [TBL] [Abstract][Full Text] [Related]
18. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma. Yang B; Wang Y; Liu T; Zhang M; Luo T Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403 [TBL] [Abstract][Full Text] [Related]
19. Construction of a prognostic risk model based on pyroptosis-related genes and comprehensive analysis of key genes and tumor immune microenvironment for colon cancer. Liu M; Zhang J; Zhao Y; Zhang X Medicine (Baltimore); 2024 Sep; 103(36):e39300. PubMed ID: 39252305 [TBL] [Abstract][Full Text] [Related]
20. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy. Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y Front Immunol; 2021; 12():665002. PubMed ID: 34367132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]